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There is increased awareness of the severe tuberculosis 
(TB)-related morbidity and mortality suffered by children 
in TB-endemic countries. Access to accurate diagnosis 
and effective treatment in TB-endemic countries has been 
facilitated by recent landmark developments. The World 
Health Organization (WHO) published guidelines for national 
TB programmes on the management of TB in children,1 and 
the Global Drug Facility (GDF) made child-friendly drug 
formulations available for the first time. However, establishing 
an accurate TB diagnosis in children, particularly in TB-
endemic settings that carry the brunt of the TB disease burden, 
remains a tenacious problem.  
Robert Koch proved that TB was a transmissible disease 
caused by Mycobacterium tuberculosis. However, it was soon 
recognised that only a small minority of people infected with 
M. tuberculosis ever progress to active disease. This explains 
why the diagnostic challenge is more pronounced in TB-
endemic countries where TB infection is exceedingly common, 
which increases the need to differentiate between latent TB 
infection (LTBI) and active disease. 
Risk assessment
Accurate risk assessment is essential, as it provides the 
rationale behind current diagnostic approaches. The most 
important variables that determine a child’s risk to progress 
from: (i) exposure to infection; and (ii) infection to active 
disease, have been identified in the pre-chemotherapy 
literature that describes the natural history of childhood TB.2  
Exposure to infection
TB is spread via tiny aerosol droplets. The risk of infection 
after exposure to an infectious source case is determined by 
the infectiousness of the source case, as well as the proximity 
and duration of contact. In TB-endemic areas the majority 
of TB transmission occurs outside the household, but this 
does not reduce the importance of household exposure when 
it is reported. Documented household exposure presents 
an important opportunity for health education and for the 
provision of preventive chemotherapy.  
Infection to disease
Table I summarises the age-dependent risk to progress to active 
TB following primary infection with M. tuberculosis.2 Recent 
observations indicate that immune-compromised (e.g. HIV-
infected) children experience a similar risk to that described 
in very young (< 2 - 3 years) immune-immature children. It is 
important to identify these variables before defining priority 
groups for preventive therapy intervention.
Diagnosis
Screening for latent TB infection and active disease
Current WHO guidelines advise that all children < 5 years 
of age in close contact with a sputum smear-positive index 
case should be actively traced, screened for TB and provided 
with preventive chemotherapy once active TB has been 
excluded1 (Fig. 1). It recognises the fact that symptom-based 
screening may have considerable value to improve the access 
of children to preventive therapy, especially in settings where 
chest radiography and tuberculin skin testing are not readily 
available. The new guidelines indicate that any ‘close contact’ 
with a sputum smear-positive index case is important, even if 
this occurs outside the household. However, a poorly defined 
history of TB contact is insufficient to ascribe risk and it is 
important to carefully consider the proximity and duration 
of contact during the period when the index case would 
have been infectious, when deciding if preventive therapy is 
warranted. The new guidelines also acknowledge that HIV-
infected (immune-compromised) children should be regarded 
as high-risk contacts, irrespective of their age.  
Diagnosing active disease
Establishing a definitive diagnosis of childhood TB remains a 
challenge. Sputum-smear microscopy is positive in less than 
10 - 15% of children with TB, and culture yields are generally 
low (30 - 40%),  although the yield seems considerably higher 
in children with advanced disease.3 In low-burden countries 
the triad of: (i) known contact with an infectious source case; 
(ii) a positive tuberculin skin test (TST); and (iii) a suggestive 
chest radiograph (CXR) is frequently used to establish a 
diagnosis of childhood TB, and it performs quite well in 
these settings.3 However, this approach has reduced value 
in endemic areas where exposure to, and/or infection with, 
M. tuberculosis is common and often undocumented.3 The 
diagnosis of TB is further complicated by the great diversity 
of disease manifestations seen in children. Table II reflects 
the disease diversity recorded among children diagnosed 
with TB in a community-based study from Cape Town. HIV-
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infected children seemed to experience a similar risk and 
developed similar disease manifestations as very young 
(immune-immature) children,4 demonstrating the importance 
of establishing a child’s HIV status to facilitate optimal 
management and care.
Symptom-based approaches
Because of the diagnostic limitations and the difficulty of 
obtaining a CXR in TB-endemic areas with limited resources, 
a variety of clinical scoring systems have been developed 
to diagnose active TB.  These are all severely limited by the 
absence of standard symptom definitions and inadequate 
validation. Accurate symptom definition is important, as 
poorly defined symptoms (such as a cough of > 3 weeks’ 
duration) have poor discriminatory power.  In a cross-sectional 
observational study well-defined symptoms with a persistent, 
non-remitting character offered far better diagnostic promise. 
The most helpful symptoms identified were: (i) persistent, 
non-remittent coughing or wheezing; (ii) documented failure to 
thrive despite deworming and food supplementation (if food 
security is a concern); and (iii) fatigue or reduced playfulness.5 
In a subsequent prospective, community-based study 
conducted in Cape Town, the presence of a persistent, non-
remitting cough, together with documented failure to thrive 
in the preceding 3 months and fatigue, provided excellent 
diagnostic accuracy in HIV-uninfected children ≥ 3 years of 
age (sensitivity 82.3%, specificity 90.2%, positive predictive 
value 82.3%).  However, these criteria performed less well in 
diagnosing the younger children (sensitivity 51.8%, specificity 
92.5%, positive predictive value 90.1%), in whom the use of a 
positive TST as the third variable instead of fatigue increased 
the sensitivity to 67.3% and retained a high specificity (93.8%).6  
In uncertain cases, where all the diagnostic criteria were 
not met at presentation, simple clinical follow-up provided 
important additional diagnostic information, by documenting 
natural symptom resolution in the vast majority of uncertain 
cases without TB. In HIV-infected children the same symptoms 
provided far less favourable results (sensitivity 56.2%, 
specificity 61.8%, positive predictive value 61.9%); in addition, 
owing to the poor sensitivity of the TST in these children, 
documented household contact with a TB index case provided 
more diagnostic value than a positive TST result.6
Radiology-based approaches
Despite its many limitations the CXR remains the most 
valuable special investigation to perform in children whose 
symptoms lead one to suspect TB.  If evaluated by an 
Table I. Age-specific risk to progress to disease following primary infection with M. tuberculosis in immune-competent 
children* 
Age at primary infection Risk to progress to disease
 < 1 year No disease                                                                                                  50%
Pulmonary disease                                                                              30 - 40%
Disseminated (miliary) disease or TBM                                              10 - 20%
1 - 2 years No disease                                                                                           75 - 80%
Pulmonary disease                                                                              10 - 20%
Disseminated (miliary) disease or TBM                                                 2 - 5%
2 - 5 years No disease                                                                                                  95%
Pulmonary disease                                                                                       5%
Disseminated (miliary) disease or TBM                                                    0.5%
5 - 10 years No disease                                                                                                  98%
Pulmonary disease                                                                                       2%
Disseminated (miliary) disease or TBM                                                 < 0.5%
 > 10 years No disease                                                                                           80 - 90%
Pulmonary disease                                                                              10 - 20%
Disseminated (miliary) disease or TBM                                                 < 0.5%
*Adapted from Marais et al.2
TBM = tuberculous meningitis.
Fig. 1. Suggested approach (WHO, 20061) to contact management when 
chest X-ray and tuberculin skin testing are not readily available (*isonia-
zid 5 mg/kg daily for 6 months; †unless the child is HIV-infected, in which 
case isoniazid 5 mg/kg daily for 6 months is indicated).
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Fig. 1. Suggested approach (WHO, 2006
1
) to contact management when chest X-ray and tuberculin
skin testing are not readily available (
*isoniazid 5/mg/kg daily for 6 months; †unless the child is HIV-
infected, in which case isoniazid 5/mg/kg daily for 6 months is indicated).
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experienced clinician it provides a fairly accurate diagnosis 
in the vast majority of TB cases, at least in HIV-uninfected 
children. High-resolution computed tomography (HRCT) 
has a role to play in complicated problem cases, but caution 
is required when interpreting the clinical relevance of this 
sensitive test, as a limited degree of hilar adenopathy is not 
uncommon in asymptomatic children following recent primary 
infection. The International Union Against Tuberculosis and 
Lung Disease (IUATLD) recently published a radiographic 
atlas of childhood TB, which serves as an excellent reference 
and training resource.7 
Other approaches
A positive culture provides a definitive diagnosis of TB in 
a symptomatic child. However, traditional culture methods 
are limited by suboptimal sensitivity, slow turnaround 
times, excessive cost and low bacteriological yields. It is 
important to point out that adolescent children (>10 years of 
age) frequently develop sputum smear-positive disease that 
may be diagnosed using traditional sputum microscopy.4 
Collecting an adequate sample presents a challenge in small 
children who cannot produce a good sputum specimen. In 
children with suspected TB lymphadenitis, the most common 
extrathoracic manifestation of childhood TB, fine-needle 
aspiration (FNA) is a robust and simple technique that 
provides a rapid and definitive diagnosis; the use of a small 
23-gauge needle is associated with minimal side-effects.8 
Immune-based diagnosis is complicated by the wide spectrum 
of disease and other factors such as BCG vaccination, exposure 
to environmental mycobacteria and HIV co-infection, all of 
which are particularly prevalent in TB-endemic areas. A more 
comprehensive overview of novel diagnostic tests and sample 
collection methods is provided in Zar’s article in this issue.9  
HIV infection
The diagnostic challenge is most pronounced in HIV-infected 
children:5,10 
1.  HIV-infected children who live with HIV-infected adults 
are more likely to be exposed to a sputum smear-negative 
index case at home. Although they are less infectious (20 - 
Table II. Disease spectrum documented in a prospective community-based survey of all children < 13 years of age, treated for 
TB in a highly endemic area*
TB manifestation
Total (%)
N = 439
Not TB
Intrathoracic TB
Ghon focus
Uncomplicated (with/without hilar adenopathy)
Complicated
Lymph node disease
Uncomplicated
Complicated
Compression
Consolidation 
Pleurisy
Pericarditis
Disseminated (miliary) disease
Adult-type disease
Extrathoracic TB
Peripheral lymphadenitis
Cervical
Other
Central nervous system TB
Meningitis
Tuberculoma
Abdominal TB
Osteo-articular TB
Vertebral spondylitis
Other
Skin
[Intra- + extrathoracic TB]
85 (19.4)
307 (69.9)
16/307 (5.2)
3/307 (1.0)
147/307 (47.9)
25/307 (8.1)
62/307 (20.6)
24/307 (7.8)
1/307 (0.3)
15/307 (4.9)
14/307 (4.6)
72 (16.4)
35/72 (48.6)
1/72 (1.4)
14/72 (19.4)
2/72 (2.8)
1/72 (1.4)
4/72 (5.6)
7/72 (9.7)
8/72 (11.1)
[25 (5.7)]
*Adapted from Marais et al.4
TB = tuberculosis; Not TB = chest radiograph not suggestive of TB (confirmed by two independent child TB experts), no bacteriological or histological proof and no extrathoracic TB 
recorded; [Intra+extra thoracic TB] = children with intra- and extrathoracic TB were included in both groups, and therefore this number should be deducted to add up to a total of 439 
or 100%. 
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40% as infectious as a sputum smear-positive patient), 
sputum smear-negative index cases still pose a significant 
transmission risk, which is often enhanced by prolonged 
diagnostic delay and the fact that no preventive therapy is 
given to close contacts.
2.  The TST has very low sensitivity in HIV-infected children, 
despite using a reduced induration size cut-off of ≥ 5 mm.3
3.  Chronic pulmonary symptoms from other HIV-related 
conditions such as gastro-oesophageal reflux and 
bronchiectasis are not uncommon and failure to thrive is 
a typical feature of both TB and HIV, greatly reducing the 
specificity of symptom-based diagnostic approaches.9
4.  CXR interpretation is complicated by HIV-related co-
morbidity such as bacterial pneumonia, lymphocytic 
interstitial pneumonitis (LIP), bronchiectasis, pulmonary 
Kaposi’s sarcoma (KS) and the atypical presentation of TB in 
immune-compromised children.10
Conclusion
In order to reduce the severe TB-related morbidity and 
mortality suffered by children in TB-endemic areas two groups 
of children require access to anti-TB therapy: (i) high-risk, 
exposed and/or infected children require access to preventive 
therapy; and (ii) all children with active disease require access 
to effective treatment. Fig. 2 presents a flow diagram to guide 
individual patient management, based on answers to five 
simple questions.  The underlying principles remain consistent, 
irrespective of the resources available in any particular setting.3 
1. Is the child exposed to or infected with M. tuberculosis? 
2. Does the child have active TB? 
3.  If the child is exposed to or infected with M. tuberculosis and 
active TB has been excluded, is preventive chemotherapy 
indicated? 
4.  If the child has active TB, what is the disease manifestation 
and appropriate treatment regimen? 
Fig. 2. Flow diagram to guide the diagnosis and management of children with suspected pulmonary tuberculosis (adapted from Marais et al.3). (*In 
non-endemic areas where the risk of re-infection is low and where TB eradication is an achievable goal, it would be desirable to provide preventive 
treatment to all individuals with documented TB infection.) 
1
NO YES
NO YES
YES
5. COMPLICATING FACTORS TO CONSIDER?
Fig. 2. Flo diagram to guide the diagnosis and appropriate management of children with suspected pulmonary
tuberculosis (adapted from Marais et al.3). (*In non-endemic areas where the risk of re-infection is low and
where TB eradication is an achievable goal, it would be desirable to provide preventive treatment to all
individuals with documented TB infection.)
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5.  Are there any special circumstances to consider such as HIV 
infection or exposure to a drug-resistant index case? 
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